Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124732703 | 12473270 | 3 | F | 20150903 | 20160629 | 20160616 | 20160704 | EXP | JP-009507513-1605JPN011050 | MERCK | 81.00 | YR | F | Y | 45.00000 | KG | 20160704 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124732703 | 12473270 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 50 MG, QAM | 12650 | MG | Y | 21995 | 50 | MG | TABLET | QD | |||
| 124732703 | 12473270 | 2 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | DAILY DOSAGE UNKNOWN | U | 0 | POWDER | ||||||||
| 124732703 | 12473270 | 3 | C | GLUCONSAN K | 2 | Oral | 6 G, QD (DIVIDED DOSE FREQUENCY UNKNOWN) | U | 0 | 6 | G | POWDER FOR ORAL SOLUTION | QD | ||||||
| 124732703 | 12473270 | 4 | C | MIYA-BM | CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 | 1 | Oral | 3 G, QD (DIVIDED DOSE FREQUENCY UNKNOWN) | U | 0 | 3 | G | POWDER FOR ORAL SOLUTION | QD | |||||
| 124732703 | 12473270 | 5 | C | GASMOTIN | MOSAPRIDE CITRATE | 1 | Oral | 1.5 G, QD (DIVIDED DOSE FREQUENCY UNKNOWN) | U | 0 | 1.5 | G | POWDER FOR ORAL SOLUTION | QD | |||||
| 124732703 | 12473270 | 6 | C | EBASTINE | EBASTINE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | TABLET | QD | |||||
| 124732703 | 12473270 | 7 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Unknown | DIVIDED DOSE FREQUENCY UNKNOWN | U | 0 | 4 | G | QD | ||||||
| 124732703 | 12473270 | 8 | C | NOVOLIN 30R | INSULIN HUMAN | 1 | Subcutaneous | DAILY DOSAGE UNKNOWN | U | 0 | INJECTION | ||||||||
| 124732703 | 12473270 | 9 | C | BESOFTEN | SODIUM ALGINATE | 1 | Topical | DAILY DOSAGE UNKNOWN | U | 0 | LIQUID | ||||||||
| 124732703 | 12473270 | 10 | C | AZUNOL (guaiazulene) | 2 | Topical | DAILY DOSAGE UNKNOWN | U | 0 | OINTMENT | |||||||||
| 124732703 | 12473270 | 11 | C | BESOFTEN | SODIUM ALGINATE | 1 | Topical | DAILY DOSAGE UNKNOWN | U | 0 | OINTMENT | ||||||||
| 124732703 | 12473270 | 12 | C | INTENURSE | 2 | Unknown | DAILY DOSAGE UNKNOWN (FORMULATION:EXT) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124732703 | 12473270 | 1 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124732703 | 12473270 | OT |
| 124732703 | 12473270 | HO |
| 124732703 | 12473270 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124732703 | 12473270 | Femoral neck fracture | |
| 124732703 | 12473270 | Pemphigoid | |
| 124732703 | 12473270 | Pneumonia aspiration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124732703 | 12473270 | 1 | 20150821 | 20160516 | 0 |